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Abstract
Gliotoxin, and other related molecules, are encoded by multi-gene clusters and biosynthesized by fungi using non-
ribosomal biosynthetic mechanisms. Almost universally described in terms of its toxicity towards mammalian cells, gliotoxin
has come to be considered as a component of the virulence arsenal of Aspergillus fumigatus. Here we show that deletion of
a single gene, gliT, in the gliotoxin biosynthetic cluster of two A. fumigatus strains, rendered the organism highly sensitive to
exogenous gliotoxin and completely disrupted gliotoxin secretion. Addition of glutathione to both A. fumigatus DgliT strains
relieved gliotoxin inhibition. Moreover, expression of gliT appears to be independently regulated compared to all other
cluster components and is up-regulated by exogenous gliotoxin presence, at both the transcript and protein level. Upon
gliotoxin exposure, gliT is also expressed in A. fumigatus DgliZ, which cannot express any other genes in the gliotoxin
biosynthetic cluster, indicating that gliT is primarily responsible for protecting this strain against exogenous gliotoxin. GliT
exhibits a gliotoxin reductase activity up to 9 mM gliotoxin and appears to prevent irreversible depletion of intracellular
glutathione stores by reduction of the oxidized form of gliotoxin. Cross-species resistance to exogenous gliotoxin is
acquired by A. nidulans and Saccharomyces cerevisiae, respectively, when transformed with gliT. We hypothesise that the
primary role of gliotoxin may be as an antioxidant and that in addition to GliT functionality, gliotoxin secretion may be a
component of an auto-protective mechanism, deployed by A. fumigatus to protect itself against this potent biomolecule.
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Introduction
Gliotoxin, which has a molecular mass of 326 Da and is an
epipolythiodioxopiperazine (ETP), contains a disulphide bridge of
unknown origin and has been shown to play a significant role in
enabling the virulence of Aspergillus fumigatus [1–3]. The cytotoxic
activity of gliotoxin is generally mediated by direct inactivation of
essential protein thiols [4] and by inhibition of the respiratory burst
in neutrophils by disrupting NADPH oxidase assembly, thereby
facilitating in vivo fungal dissemination [5,6]. The enzymatic
machinery responsible for gliotoxin biosynthesis, and metabolism,
is encoded by a multi-gene cluster in A. fumigatus which is
coordinately expressed during gliotoxin biosynthesis [7,8]. This
cluster encodes gliP, a bimodular nonribosomal peptide synthetase
(NRPS) which has been conclusively shown to be responsible for the
biosynthesis of a Phe-Ser dipeptide, a gliotoxin precursor, by gene
disruption (DgliP mutant) [9–12]. In fact, disruption of gliP within
the gliotoxin biosynthetic cluster has resulted in the effective
inhibition of all cluster gene expression in a DgliP mutant [9]. A
putative transporter, encoded by gliA, has been shown to facilitate
gliotoxin efflux, and increased tolerance to exogenous gliotoxin,
when expressedinLeptosphaeria maculans[13]. sirAis a gliAortholog in
this organism and L. maculans DsirA was more sensitive to exogenous
gliotoxin and sirodesmin than wild-type, however restoration of sirA
in the mutant led to greater tolerance towards these metabolites
[13]. Bok et al. [14] have demonstrated that disruption of a fungal
Zn(II)2-Cys(6) binuclear cluster domain transcription factor (gliZ)
results in the complete inhibition of all gliotoxin cluster gene
expression and effective diminution of gliotoxin production [14].
Although GliP has been shown to activate and condense L-Phe and
L-Ser to form a precursor diketopiperazine moiety, no information
relating to subsequent modification (e.g., thiolation) is available [9–
12,15] and it is also unclear if A. fumigatus might need to protect itself
against potential gliotoxin cytotoxicity [13].
Interestingly, addition of gliotoxin (up to 5 mg/ml) to A. fumigatus
DgliP resulted in the up-regulation of selected gene expression (gliI,
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complete activation of the gene cluster (except gliP) following
gliotoxin exposure (20 mg/ml). However, exposure of wild-type A.
fumigatus Af293 to gliotoxin (20 mg/ml), for 24 h, did not result in
any significant alteration in gliotoxin cluster expression [9]. The
biological significance of these observations is unclear, apart from
implying a role for gliotoxin in the regulation of the gli cluster in
the absence of gliotoxin production.
It has recently been demonstrated that gliotoxin and spor-
idesmin, also an ETP toxin containing a disulphide bridge, are
both substrates and inactivators of glutaredoxin (Grx1) [16]. These
authors also confirmed that the intact disulphide form of these
ETP moieties was essential for Grx1 inactivation and that prior
reduction of sporidesmin, using glutathione, prevented subsequent
Grx1 inactivation. Oxygen presence was also required for Grx1
inactivation by sporidesmin and mass spectrometric analysis
confirmed the formation of mixed disulphides between one
molecule of Grx1 and either gliotoxin or sporidesmin, respectively.
Combined, these data suggest interplay between oxygen availabil-
ity and selective protein inactivation in the presence of oxidised
ETP-type molecules. This indirectly suggests either a protective, or
neutral, involvement of the oxidised forms of gliotoxin or
sporidesmin in protecting against the deleterious effects of oxygen
by selective protein inactivation.
In mammalian cells it has been demonstrated that the oxidized
form of gliotoxin is actively concentrated in a glutathione-
dependent manner and that it then exists within the cell almost
exclusively in the reduced form [17]. As glutathione levels fall due
to apoptosis, the oxidized form of gliotoxin effluxes from the cell
where the cytocidal effects of gliotoxin are perpetuated in a
pseudocatalytic manner. Conversely, it has been shown that
gliotoxin may substitute for 2-cys peroxiredoxin activity in HeLa
cells by accepting electrons from NADPH via the thioredoxin
reductase–thioredoxin redox system to reduce H2O2 to H2O. In
this way, nanomolar levels of gliotoxin may actually protect
against intracellular oxidative stress [18].
Although the cytotoxic effects of gliotoxin on mammalian cells
have been extensively investigated, and yeast have been deployed
as a model system to study this interaction [19], no direct
investigation of any self-protective mechanism used by A. fumigatus
against this intriguing molecule has been undertaken. Here, we
demonstrate that deletion of gliT results in transformants which
cannot grow in the presence of even modest levels of exogenous
gliotoxin and that exogenous gliotoxin up-regulates gene expres-
sion within the gliotoxin cluster, especially that of gliT. We propose
that GliT is the key cellular defence against gliotoxin in A. fumigatus
and that this finding yields a new selection marker system for
detecting transformation.
Results
Deletion and complementation of gliT in A. fumigatus
DgliT mutants were generated by transformation of A. fumigatus
strains ATCC46645 and ATCC26933, respectively, as described
in Materials and Methods, using the bipartite marker technique
and pyrithiamine selection, with modifications [20,21] (Figure S1).
Deposition number: IMI CC 396691 (CABI Bioscience Centre,
Egham, Surrey, UK). These two strains were chosen because
ATCC26933 is a gliotoxin producer, whereas ATCC46645 lacks
significant gliotoxin production using the Minimal Media
described in Materials and Methods (see below). Complementa-
tion of gliT mutant strains was carried out as described in
Materials and Methods and Figure S1). Complemented strains
(gliT
C) (Deposition number: IMI CC 396692) exhibited wild-type
like features in all subsequent experiments, demonstrating that the
occurrence of a single ectopic integration of a gliT fragment is
insignificant in the A. fumigatus ATCC26933 background.
Gliotoxin prevents growth of DgliT strains
DgliT protoplasts grew and regenerated mycelia perfectly in the
absence of gliotoxin (Figure 1A). The DgliT strain grew at identical
rates to wild-type (data not shown). However, DgliT protoplasts
were unable to grow in the presence of gliotoxin (10 mg/ml)
(Figure 1A) whereas exogenous gliotoxin had no effect on wild-
type growth. Subsequent phenotypic analysis of A. fumigatus
ATCC46645, ATCC26933, and respective DgliT conidia
(DgliT
46645 and DgliT
26933) demonstrated that gliotoxin (5 mg/ml)
significantly inhibited DgliT growth on minimal medium and
completely inhibited DgliT growth on both AMM and Sabouraud
medium (gliotoxin, 10 mg/ml) (Figure 1B & C; p,0.0001 and
Figure S2). Moreover, germination rates of DgliT strains were
comparable to those of wild-type A. fumigatus, even in the presence
of gliotoxin up to 10 mg/ml. These results clearly indicated that
DgliT was highly sensitive to exogenous gliotoxin. Consequently,
DgliT
46645 and DgliT
26933 mutant complementation was carried
out by introducing gliT only (no antibiotic resistance gene) to
complement DgliT with selection in the presence of gliotoxin
(10 mg/ml). Transformants, which had recovered resistance to
exogenous gliotoxin, were confirmed by Southern analysis to have
an intact and functional copy of gliT present (Figure S1). This
result confirms that gliT confers resistance to gliotoxin in A.
fumigatus and that DgliT mutants have significant potential for
future functional genomic studies involving A. fumigatus since gene
deletions in this strain are selectable by gliT reintroduction, with
selection in the presence of gliotoxin.
Remarkably, addition of reduced glutathione (GSH; 20 mM)) to
test plates completely abolished the cytotoxic effects of exogenous
gliotoxin which indicated that gliT loss resulted in depletion of
intracellular GSH, when exposed to gliotoxin, or that only the
oxidized form of gliotoxin is imported into A. fumigatus (Figure 1B
& C). Prior reduction of gliotoxin, using 50 mM NaBH4, resulted
in a statistically significant inhibitory effect of gliotoxin on growth
of DgliT
26933 (p,0.05) (Figure 1B & C). NaBH4 was selected as
Author Summary
The pathogenic fungus Aspergillus fumigatus causes
disease in immunocompromised individuals such as cancer
patients. The fungus makes a small molecule called
gliotoxin which helps A. fumigatus bypass the immune
system in ill people, and cause disease. Although a small
molecule, gliotoxin biosynthesis is enabled by a complex
series of enzymes, one of which is called GliT, in A.
fumigatus. Amazingly, nobody has really considered that
gliotoxin might be toxic to A. fumigatus itself. Here we
show that absence of GliT makes A. fumigatus highly
sensitive to added gliotoxin and inhibits fungal growth,
both of which can be reversed by restoring GliT. Neither
can the fungus make or release its own gliotoxin when GliT
is missing. We also show that gliotoxin sensitivity can be
totally overcome by adding glutathione, which is an
important anti-oxidant within cells. We demonstrate that
gliotoxin addition increases the production of GliT, and
that GliT breaks the disulphide bond in gliotoxin which
may be a step in the pathway for gliotoxin protection or
release from A. fumigatus. We conclude that gliotoxin may
mainly be involved in protecting A. fumigatus against
oxidative stress and that it is an accidental toxin.
GliT Function in A. fumigatus
PLoS Pathogens | www.plospathogens.org 2 June 2010 | Volume 6 | Issue 6 | e1000952reductant as it avoided complications associated with the
introduction of additional thiols, or GSH, and the formation of
gliotoxin conjugates, which may have resulted from GSH, DTT or
b-mercaptoethanol-mediated reduction. It was also observed that
GSH presence (8 mM) partially alleviated the growth inhibitory
effects of gliotoxin (with or without prior reduction; p,0.01 and
p,0.005, respectively) (Figure 1C). However, wild-type levels of
growth were only achieved in the presence of 20 mM GSH
(Figure 1B). The enhanced GSH-mediated alleviation of gliotoxin-
induced cytostatic effects observed in DgliT, strongly suggest that
depletion of intracellular glutathione may be a consequence of gliT
loss. GSH-mediated relief of A. fumigatus DgliT growth inhibition,
by exogenous NaBH4-reduced gliotoxin, indicates that intracellu-
lar GSH depletion plays a role in the inhibitory effect of gliotoxin-
and not that GSH is merely acting to reduce exogenously added
gliotoxin and prevent uptake (Figure 1B & C). Exogenous gliotoxin
or reduced gliotoxin had no effect on growth of DgliZ and gliZ
c
(gliZ complemented strain) [14] (kind gifts from Professor Nancy
Keller, University of Wisconsin-Madison) and an identical pattern
was observed in the presence of GSH (data not shown). Moreover,
A. fumigatus DgliT did not exhibit any phenotype when exposed to
either H2O2 or phleomycin (data not shown). A. fumigatus gliT
C
strains were resistant to exogenous gliotoxin (Figure 1D).
Gliotoxin induces expression of the gliotoxin gene cluster
gliZ, A and G encode the gliotoxin cluster transcription factor,
transporter and a putative glutathione s-transferase (generally a
detoxification enzyme), respectively, and all are conceivably
involved in protection against gliotoxin toxicity [3,8,22]. Northern
analysis showed that expression of these 3 genes plus gliT, from the
gliotoxin gene cluster, was induced in A. fumigatus ATCC46645
within 3 h following gliotoxin (5 mg/ml) addition at 21 h
Figure 1. Exogenous gliotoxin specifically inhibits growth of A. fumigatus DgliT. (A) Protoplasts of A. fumigatus wild-type (ATCC46645) and
DgliT were poured onto AMM plates, in the presence or absence of gliotoxin (10 mg/ml). Plates were incubated for 48 h at 37uC. (B) Conidia (A.
fumigatus ATCC26933 and DgliT; 10
4/spot) were dotted on AMM plates containing the indicated supplement and incubated for 48 h at 37uC. To
obtain reduced gliotoxin (rGT) free of additional thiols, 10 mg/ml GT was reduced with 50 mM NaBH4 for 60 min at room temperature. Gliotoxin (GT)
and rGT were added at a final concentration of 10 mg/ml. (C) Quantification of radial growth of A. fumigatus ATCC26933, DgliT, DgliZ and
complemented DgliZ (gliZ
c) [14] in the presence of gliotoxin and rGT, with and without exogenous GSH. Strains (10
4 conidia) were dotted on AMM
containing GT (gliotoxin; 10 mg/ml), rGT (10 mg/ml), or reduced glutathione (8 mM), respectively. Colony diameter was measured after 48 h of
incubation at 37uC and experiments were repeated in triplicate. * indicates a significance level of p,0.0001 and # indicates p,0.05. Note: For clarity,
A. fumigatus DgliZ and gliZ
c (gliZ complemented) data are only shown for AMM +/2 GT only, as their growth was unaffected by all conditions tested.
(D) A. fumigatus DgliH is unaffected by gliotoxin presence. 10
4 conidia were spotted on AMM with GT (10 mg/ml, bottom) or without GT (top). Plates
were incubated for 72 h (hence the visible background growth of DgliT). A. fumigatus DgliH did not show any sign of an altered growth phenotype in
the presence of gliotoxin.
doi:10.1371/journal.ppat.1000952.g001
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the expression of all other genes was identical to the wild-type,
including the continued absence of expression at 24 h in the
absence of added gliotoxin (Figure 2A). Expression of gliT was
restored in pyrithiamine-resistant A. fumigatus gliT
C derived from
both ATCC46645 and ATCC26933 strain backgrounds, which
unambiguously confirms restoration of gliT expression in comple-
mented strains (Figure 2B). Moreover, gliT expression was
inducible by addition of gliotoxin (5 mg/ml), as had been observed
in both wild-type strains, thereby convincingly demonstrating that
the wild-type phenotype had been entirely restored (Figure 2B). As
noted above, no significant growth inhibition of A. fumigatus DgliZ
in particular, or gliZ
c, was observed in the presence of gliotoxin or
reduced gliotoxin (Figure 1C). These observations further confirm
the minimal role played by any other component of the gli gene
cluster in protection against gliotoxin presence since gliZ absence
results in complete cluster attenuation [14]. Significantly, North-
ern analysis confirmed gliotoxin-induced gliT expression in DgliZ,
which indicates the independent regulation of gliT with respect to
other gli cluster components, such as gliG and gliA which are not
expressed by A. fumigatus DgliZ following exposure to gliotoxin
(Figure 2C). These observations are in complete accordance with
proteomic data which demonstrated a threefold up-regulation of
GliT expression (33% sequence coverage) in A. fumigatus
ATCC26933, and the absence of detection of any other gli cluster
component, following 3 h exposure to exogenous gliotoxin (14 mg/
ml) (Figure 2D and Figure S3).
Genes immediately adjacent to gliT in the gliotoxin gene
cluster do not mediate resistance to exogenous gliotoxin
Sequence analysis of the 59 and 39 regions adjacent to the
original gliT locus in A. fumigatus DgliT
26933 confirmed that gliF was
intact but revealed two mutations (C23R and E160G) in the open
reading frame of a gene (AFUA_6G09745; identified as a
conserved hypothetical protein at http://www.cadre-genomes.
org.uk (but here termed gliH), located 39 with respect to the gliT
locus. Although expression of gliF and gliH was confirmed by RT-
PCR in A. fumigatus DgliT
26933 (Figure 2E), there was concern that
the altered sequence of gliH may have resulted in a mutant
enzyme, which could possibly have also contributed to gliotoxin
sensitivity in DgliT
26933. However, A. fumigatus DgliH
26933 grew in
the presence of gliotoxin (10 mg/ml) (Figure 1D) which completely
eliminated the possibility that this gene, located adjacent to gliT in
the A. fumigatus genome, contributed to gliotoxin resistance and
established, beyond question, the key role of gliT in mediating
resistance to exogenous gliotoxin. A. fumigatus gliH
C (Figure S1) was
also resistant to exogenous gliotoxin, as expected (Figure 1D).
Gliotoxin is not produced by A. fumigatus DgliT
Gliotoxin (580 ng/ml) was detectable in organic extracts from
A. fumigatus ATCC26933 but not DgliT
26933 cultures, grown under
identical conditions, by RP-HPLC and LC-MS analysis (Figure 3).
Gliotoxin production was recovered in A. fumigatus ATCC26933
gliT
C (Figure S4) Interestingly, DgliT
26933 exhibited an identical
phenotype to DgliT
46645 which was generated from A. fumigatus
Figure 2. gliT expression. (A) Northern analysis of the induction of gliotoxin gene cluster expression in A. fumigatus ATCC46645 and DgliT. Lanes 1,
2 and 3 correspond to A. fumigatus RNA extracts from 21 h AMM, 21 h AMM shifted to gliotoxin (5 mg/ml) for 3 h and 24 h AMM, respectively. (B)
Gliotoxin induction of gliT expression in A. fumigatus gliT
C strains. Lanes 1–6 and 7–12 contain RNA from strains in the ATCC46645 and ATCC26933
backgrounds, respectively. Lanes 1 and 7: A. fumigatus DgliT 24 h AMM; Lanes 2 and 8: A. fumigatus DgliT 21 h AMM+3 h gliotoxin (5 mg/ml); Lane 3
and 9: A. fumigatus gliT
C 24 h AMM; Lanes 4 and 10: A. fumigatus gliT
C 21 h AMM+3 h gliotoxin (5 mg/ml); Lanes 5 and 11: A. fumigatus wt 24 h AMM;
Lane 6 and 12: A. fumigatus wt 21 h AMM+3 h gliotoxin (5 mg/ml). (C) Expression of gliT in DgliZ following exposure to gliotoxin. Cultures of A.
fumigatus ATCC46645 (lanes 1 and 2) and DgliZ (lanes 3 and 4) were grown for 24 h in AMM (Lane 1 and 3) or pulsed with gliotoxin (5 mg/ml) after
21 h and cultured for a further 3 h (Lane 2 and 4). Although gliotoxin induced expression of gliA and gliG in wild-type, neither gliA or gliG are
expressed in DgliZ. All Northern analyses were performed with 10 mg of total RNA isolated from strains grown in AMM for 24 h with or without
gliotoxin. (D) A. fumigatus GliT expression and identification. Quantitative 2D-PAGE analysis confirmed increased expression (threefold) of GliT
following exogenous gliotoxin (GT) addition to A. fumigatus cultures (GliT appears to exist as two isoforms of different pI (5.5–5.6) and Mr). Peptides
identified by MALDI-ToF mass spectrometry are highlighted in bold (33% sequence coverage) and mass spectrum is given in Figure S3. (E) Semi-
quantitative RT-PCR of gliT adjacent genes in A. fumigatus wild-type (wt) (ATCC26933) and isogenic mutant strains. Expression of gliF and
AFUA_6g09745 (gliH) was examined. As a control tubA expression was monitored. As a negative control genomic DNA (gDNA) was used as template.
Lane 1: A. fumigatus DgliT
26933 24 h AMM. Lane 2: A. fumigatus DgliT
26933 21 h AMM+3 h gliotoxin (5 mg/ml). Lane 3: A. fumigatus gliT
C 24 h AMM.
Lane 4: A. fumigatus gliT
C 21 h AMM+3 h gliotoxin (5 mg/ml). Lane 5: A. fumigatus wt 24 h AMM. Lane 6: A. fumigatus wt 21 h AMM+3 h gliotoxin
(5 mg/ml).
doi:10.1371/journal.ppat.1000952.g002
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the culture conditions employed, in both A. fumigatus ATCC46645
and DgliT
46645 indicating that sensitivity to exogenous gliotoxin is
not associated with a de novo gliotoxin biosynthetic capacity. A
metabolite with retention time (Rt)=11.7 min (A220 nm) was
apparent in DgliT
26933 extracts which was absent in wild-type
extracts (Figure 3). This material was purified to assess any growth
inhibitory effect, however when added to AMM cultures of DgliT
or wild-type no alteration of growth rates was observed (data not
shown). High resolution LC-ToF MS analysis of the metabolite
(from Figure 3B) confirmed the presence of a molecular ion with a
mass of 279.0796 m/z ((M+H)
+) (Figure S4). This accurate mass
value (279.0796 m/z) corresponded to a predicted molecular
formula of C13H15N2O3S for the ion whereby the calculated exact
mass for C13H15N2O3S + H
+ was 279.0798 Da using Agilent
Technologies Masshunter workstation software. This result
suggests that a monothiol form of gliotoxin could have been
secreted from A. fumigatus DgliT
26933. A molecular species of m/z
279, which yielded daughter ions of m/z 261.1, 231.0 and 203.1,
upon MS
2 analysis, was also detected by LC-MS analysis of the
purified gliotoxin-related metabolite from A. fumigatus DgliT
26933
(Figure S4). Gliotoxin was not produced by A. fumigatus DgliH
26933
(Figure S4) which strongly supports a role for this gene in gliotoxin
biosynthesis or secretion, but not protection against exogenous
gliotoxin. This result was further consolidated whereby no
gliotoxin production was detectable, by HPLC-DAD or LC-MS,
in A. fumigatus DgliT
26933gliH (data not shown), which was generated
by restoration of the fully intact gliH in gliT-deficient A. fumigatus
(Figure S1).
GliT exhibits a gliotoxin reductase activity
Recombinant GliT was expressed in, and purified by differential
extraction from, E.coli with a yield of approximately 5.7 mg per
gram of cells. However the protein was completely insoluble and
was refractory to any attempts at refolding for activity analysis
(data not shown). SDS-PAGE analysis confirmed a subunit
molecular mass of 38 kDa for recombinant GliT (Figure S5),
which appears to migrate as a dimer under non-reducing
conditions (Figure S5), and protein identity was unambiguously
confirmed by MALDI-ToF MS whereby peptides (following
tryptic digestion) were identified yielding 21% sequence coverage
(Figure S6). Immunoaffinity purification of GliT-specific human
IgG was achieved by incubation of human sera with Sepharose-
coupled recombinant GliT. The specificity of this GliT-specific
human IgG was confirmed by the successful detection of native
GliT in both A. fumigatus cell lysates, and partially-purified extracts
of A. fumigatus (Protocol S1; Figure 4). Notably, GliT was not
detectable in A. fumigatus DgliT (Figure 4).
Previous hypotheses have suggested that GliT may only exhibit
gliotoxin oxidase activity (responsible to disulphide bridge closure
during biosynthesis) (3, 8, 22). However, following gliotoxin
induction of A. fumigatus ATCC46645, enhanced GliT activity was
evident in cell lysates and native GliT was partially purified by
ammonium sulphate precipitation and ion-exchange chromatog-
raphy (Figure S7). Data presented in Figure 5A confirm that
partially-purified native GliT specifically catalyses the NADPH-
mediated reduction of oxidized gliotoxin, whereby NADPH
oxidation is only evident in the presence of both gliotoxin
(9 mM) and GliT-containing lysates. Hence, GliT appears to
exhibit gliotoxin reductase activity which can catalyse disulphide
bridge cleavage, at concentrations up to 9 mM gliotoxin
(Figure 5B). This activity is inhibited at higher gliotoxin
concentrations (.12 mM). Not unexpectedly, A. fumigatus cell
extracts appear to contain basal NADPH oxidase activity which
yields background, non-specific NADPH oxidation (Figure 5A).
Thus, A. fumigatus ATCC46645 and DgliT lysates, generated
without prior gliotoxin induction of GliT expression, exhibit near-
identical activity. However, significantly greater gliotoxin reduc-
tase activity (2:1) was apparent in A. fumigatus ATCC46645, than
DgliT, cell lysates following gliotoxin exposure (Figure 5C).
Figure 3. Gliotoxin is not produced by A. fumigatus DgliT. (A) HPLC chromatogram of an organic extract from A. fumigatus ATCC26933
indicating gliotoxin presence with Rt=14.5 min. (B) HPLC chromatogram of organic extracts from A. fumigatus DgliT
26933 indicating gliotoxin absence
but a new metabolite with Rt=11.7 min. (C) LC-MS analysis of an organic extract from A. fumigatus ATCC26933 indicating gliotoxin presence. (D) LC-
MS analysis of A. fumigatus DgliT
26933 confirms absence of secreted gliotoxin. (E) MS
2 of gliotoxin present in wild-type A. fumigatus indicating
expected sub-fragments as noted previously [10].
doi:10.1371/journal.ppat.1000952.g003
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cell lysates (Figure S7) using human IgG [anti-GliT] resulted in a
51% reduction of gliotoxin reductase (NADPH oxidase) activity
(Figure 5D), in complete accordance with data in Figure 5C,
further confirming enzyme specificity. Interestingly, GliT activity
was not enhanced in the presence of thioredoxin from Spirulina sp.,
in activity assays, which indicates that GliT is specific for gliotoxin
reduction and that it may operate independently of cellular
thioredoxin reductase/thioredoxin systems.
Expression of GliT in A. fumigatus was further explored by
fluorescence confocal microscopy. Data in Figure S8A-C confirm
transformation of A. fumigatus DgliT
46645 and that gliT-gfp
expression is enhanced by gliotoxin addition. As shown in Figure
S8A, it appears that low-level GliT expression is evident
throughout mycelia without gliotoxin addition. However, follow-
ing mycelial exposure to gliotoxin (5 mg/ml), an enhancement of
GliT expression in the cytoplasm, and in nuclei, as shown by
fluorescence intensities (Figure S8B & C), is observed - which is in
Figure 4. Immunoaffinity purified human IgG detects native GliT in A. fumigatus. (A) SDS-PAGE and (B/C): Western blot analysis of A.
fumigatus cell lysates. Immuno-affinity purified human IgG[anti-GliT] was used for Western analysis followed by anti-human IgG-HRP conjugate with
visualization by either (B) diaminobenzidine or (C) ECL detection. Lane M: Mr marker: Lane 1: A. fumigatus ATCC26933 lysate (72 h culture); Lane 2: A.
fumigatus ATCC46645 lysate (24 h culture); Lane 3: A. fumigatus ATCC46645 DgliT lysate (24 h culture) and Lane 4: Recombinant GliT (2 mg).
Immunoaffinity purified human IgG to GliT identified GliT in all except A. fumigatus DgliT, however ECL substrate was required to detect low level GliT
expression in A. fumigatus ATCC46645 (lane C.2).
doi:10.1371/journal.ppat.1000952.g004
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activity observations. Expression of GliT-GFP fusion protein
completely restored gliotoxin resistance (10 mg/ml), although
colonies appeared white (Figure S9).
The concordance of these data lead us to conclude that a GliT-
mediated gliotoxin reductase activity is induced by exposure of A.
fumigatus to gliotoxin.
GliT is not required for A. fumigatus virulence in Galleria
mellonella
A prerequisite for testing A. fumigatus DgliT virulence was to
evaluate the utility of our G. mellonella infection model. To this end,
assessment of the relative virulence of A. fumigatus DgliZ and
corresponding wild-type in G. mellonella, in either the presence or
absence of added gliotoxin, was assessed (Figure S10). Here, all
Galleria exposed to A. fumigatus DgliZ were alive at 24 h and the
wild-type strain exhibited greater virulence than DgliZ (60% (12/
20) versus 20% (4/20) mortality, respectively), at 48 h post-
inoculation, thereby confirming the utility of the model system for
detection of alteration in virulence associated with gliotoxin
production. To assess now the relative contribution of gliT to
virulence of A. fumigatus we compared the survival of larvae of the
greater wax moth G. mellonella following infection with 10
6
conidia/larvae of A. fumigatus ATCC26933 and gliT
C to that of
larvae (n=20) infected with the same dose of DgliT
26933 (Figure
S10). For all groups of infected larvae, 100% mortality was
recorded after 72 h and the degree of melanisation was not
distinguishable between these groups. Also, pretreatment of larvae
with gliotoxin (0.5 mg/larva in 20 ml) did not lead to an
attenuation of virulence of DgliT (Figure S10). Notably, similar
results were obtained using ATCC46645 and DgliT
46645 strains
(data not shown). These results clearly show that, gliT has a
minimal, if any, role to play in the virulence of A. fumigatus
employing a Galleria model.
GliT confers protection against exogenous gliotoxin in
Aspergillus nidulans and Saccharomyces cerevisiae
Reintroduction of gliT into A. fumigatus DgliT was selected for in
the presence of gliotoxin and no additional selection marker was
required (Figure S1 and Figure 1D). To further test the ability of
gliT to confer resistance to gliotoxin, and its future potential as a
selection marker gene, we introduced gliT into A. nidulans which
does not produce gliotoxin and neither does it contain any genes
involved in gliotoxin biosynthesis [22,23]. The absence of gliT, and
cognate gene expression, in A. nidulans was confirmed by Southern
and Northern analysis (Figure 6A & B). Subsequent transforma-
tion of A. nidulans with A. fumigatus-derived gliT resulted in the
generation of three transformants (An
gliT 1, 2 and 3) (Deposition
number: IMI CC 396693), which were shown by Northern
analysis to express gliT to different extents (Figure 6B). This led to
acquisition of resistance to high levels of exogenous gliotoxin
(50 mg/ml) (Figure 6C) thereby confirming the key role of gliT in
protection against gliotoxin toxicity in gliotoxin-naı ¨ve fungi. The
gliT coding sequence was also transformed into the genetically
distant yeast, S. cerevisiae BY4741, under control of the constitutive
SSA2 promoter [24] in plasmid pC210. As can be seen in
Figure 6D, yeast transformed with plasmid-encoded gliT were
capable of growth in the presence of gliotoxin (16 and 64 mg/ml,
respectively) depending on whether minimal or rich media was
used to support growth, while those transformed with empty
vector were unable to grow, irrespective of what media conditions
were used. These observations further confirm the pivotal role of
Figure 5. GliT exhibits a gliotoxin reductase activity. (A) No GliT activity (gliotoxin reductase) is detectable in the absence of gliotoxin or GliT (1
& 2). Background NADPH oxidase activity is detectable in semi-purified A. fumigatus cell extracts (3) (Figure S5), however, GliT-mediated gliotoxin
reductase activity is detectable upon addition of gliotoxin (4). (B) In vitro, optimal GliT gliotoxin reductase activity is observed up to 9 mM gliotoxin.
This activity is inhibited at higher gliotoxin concentrations (.12 mM). (C) Relative gliotoxin reductase activity in cell lysates from DgliT compared to A.
fumigatus ATCC46645 with gliotoxin addition during culture. Wild-type lysates exhibit enhanced gliotoxin reductase activity (47%) consequent to
elevated GliT expression. (D) Immunodepletion of GliT from semi-purified A. fumigatus cell extracts (Figure S5), using immunoaffinity purified human
IgG [anti-GliT], results in a 51% decrease in gliotoxin reductase activity.
doi:10.1371/journal.ppat.1000952.g005
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which do not normally contain the gene or biosynthesise gliotoxin.
Discussion
Studies into the biosynthesis and pathogenicity of gliotoxin have
attracted significant recent attention, stimulated in part by the
plethora of fungal genome data now emerging [3,22]. Here, we
demonstrate for the first time that disruption of gliT, found within
the gliotoxin biosynthetic cluster, but subject to differential
regulation, completely sensitizes A. fumigatus to exogenous
gliotoxin, and abolishes gliotoxin secretion. The possibility that
genes adjacent to gliT in the gliotoxin gene cluster (gliF or gliH)
play a role in auto-protection is excluded. Thus, we have
elucidated a key cellular protective mechanism against the hitherto
unknown, potent auto-toxicity of gliotoxin in A. fumigatus.
Exposure of A. fumigatus DgliT to gliotoxin appears to result in
depletion of intracellular GSH since the inhibitory phenotype can
be completely relieved by GSH supplementation. Furthermore, we
demonstrate the enzymatic functionality of GliT as a gliotoxin
reductase and that GliT reactivity is evident in human sera. We
demonstrate that gliT confers resistance to exogenous gliotoxin,
independently of the extent of gliT expression, following
transformation in naı ¨ve hosts, A. nidulans and S. cerevisiae. Finally,
identification of gliT complementation in A. fumigatus DgliT
46645
and
26933, respectively, was selected for in the presence of gliotoxin
which supports a selection marker role for gliT in A. fumigatus
transformation experimentation.
To date, the potential requirements for self-protection against
gliotoxin, in A. fumigatus, have not been studied. The ETP toxin,
sirodesmin, is produced by the fungus Leptosphaeria maculans with
biosynthesis encoded by a multigene cluster similar to that
responsible for gliotoxin production in A. fumigatus [13]. Deletion
of the sirodesmin transporter gene, sirA,i nL. maculans led to
increased sensitivity to exogenous sirodesmin and gliotoxin,
however the A. fumigatus gliotoxin transporter, GliA, was shown
to confer resistance to exogenous gliotoxin (10 mM), but not
sirodesmin, in L. maculans DsirA. Interestingly, production and
secretion of sirodesmin was actually increased by 39% in L.
maculans DsirA compared to wild-type and resulted in speculation
as to the presence of alternative toxin efflux mechanisms [13].
Based on our observations, we hypothesise that in addition to the
likely role of gliA in gliotoxin efflux in A. fumigatus, GliT may play
an essential role in the auto-protective strategy against the
deleterious effects of the ETP toxin. Moreover, we predict that
gliT orthologs in other fungi [22] may play similar, if not identical
roles.
Our results indicate that absence of GliT may lead to
accumulation of intracellular gliotoxin which is reduced, non-
enzymatically, by GSH, analogous to the situation in animal cells
as demonstrated by Bernardo et al. [17]. The concomitant
depletion of intracellular GSH levels, allied to the cytotoxicity of
reduced gliotoxin, results in strong growth inhibition, possibly
mediated by disruption of the cellular redox status and significant
protein modification by gliotoxin. This conclusion is strongly
supported by the observation that addition of GSH, during
exposure of A. fumigatus DgliT to gliotoxin, effectively completely
reverses the cytostatic effects of gliotoxin. While we cannot exclude
the possibility that added GSH is merely reducing exogenously
added gliotoxin and preventing import of the reduced form, it is
Figure 6. Transformation of A. nidulans and S. cerevisiae with gliT facilitates resistance to exogenous gliotoxin. (A) Southern analysis
confirms that two A. nidulans transformants contain gliT (An
gliT 7 and 8) compared to A. nidulans wild-type (An-wt). wt: A. fumigatus (positive control
for gliT). Genomic DNA was digested with PstI and probed for the presence of A. fumigatus gliT. (B) Northern analysis of gliT in An-wt, An
gliT (7 and 8)
and A. fumigatus wild-type (wt). RNA was isolated using TRI-reagent and 10 mg of total RNA were probed with a gliT-specific probe. (C) Plate assay of
A. nidulans wild-type and A. nidulans expressing gliT (An
gliT 7 and 8). A. nidulans wild-type and An
gliT (10
4) conidia were dotted on AMM and on AMM
containing gliotoxin (50 mg/ml). Growth was monitored over a period of 72 h at 37uC. Genotypes of strains are described in Table 1. (D) GliT confers
gliotoxin resistance on S. cerevisiae. Spots represent equal numbers of yeast cells plated onto medium containing gliotoxin at the concentrations
indicated. Plates were incubated at 30uC for two days followed by a further three days at room temperature.
doi:10.1371/journal.ppat.1000952.g006
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results in significant growth inhibition of A. fumigatus DgliT
(p,0.05). The observed alleviation of this inhibition (by NaBH4-
reduced gliotoxin), in the presence of added GSH, supports the
proposal that intracellular GSH depletion is a consequence of gliT
disruption, when growth occurs in the presence of exogenous
gliotoxin.
Addition of gliotoxin (up to 20 mg/ml) for 24 h resulted in the
complete up-regulation of the gene cluster (except gliP)i nA.
fumigatus DgliP, but not in A. fumigatus wild-type [9]. We
demonstrate that exposure to exogenous gliotoxin for 3 h does
induce GliT expression in A. fumigatus wild-type at the transcript
and protein level, in fact these data also represent the first
confirmed identification of a protein encoded by the gliotoxin
biosynthetic cluster. The discrepancy, possibly due to 3 versus
24 h experimental windows, nonetheless, indicates differential
GliT expression relative to other gli genes. Disruption of gliZ, the
transcriptional regulator of the gliotoxin biosynthetic cluster, has
been shown to result in abolition of gliotoxin production and loss
of gliotoxin cluster gene expression [14]. Our data demonstrate
that although growth of A. fumigatus DgliZ and gliZ
c is unaffected by
exogenous gliotoxin, gliZ expression is up-regulated in response to
exogenous gliotoxin exposure in A. fumigatus ATCC46645, but to a
lesser extent than that of gliT (Figure 2). In addition, we have
shown that gliT expression is induced by gliotoxin addition to
liquid cultures of A. fumigatus DgliZ thereby confirming the
independent regulation of gliT expression to other cluster
components (e.g., gliA and gliG). In combination, these observa-
tions further confirm the minimal role played by any other
component of the gli gene cluster in protection against gliotoxin
presence since gliZ absence results in complete cluster attenuation
[14], except for gliT.
A thioredoxin system in A. nidulans has recently been described
whereby a thioredoxin mutant exhibited decreased growth,
impaired reproductive function and altered catalase activity [25].
These authors also identified a thioredoxin reductase (termed
AnTrxR) which functions to regenerate reduced thioredoxin in A.
nidulans. Our BLAST analysis indicates minimal identity between
GliT and AnTrxR as well as between GliT and a second putative
thioredoxin reductase in A. fumigatus (Genbank accession number:
EAL85952; 30% identity). This strongly indicates distinct
functionality of gliT and confirms that alternative thioredoxin
reductase activities cannot compensate for loss of gliT in A.
fumigatus. It further appears unlikely that thioredoxin is involved in
mediating GliT activity since no thioredoxin reductase present in
A. fumigatus cell lysates appears capable of compensating for GliT
absence. Consequent to its bioinformatic classification as a
thioredoxin reductase, GliT has been predicted by many authors
to encode disulphide bond formation in gliotoxin and to play a
role in gliotoxin biosynthesis [3,8,22]. While this ‘gliotoxin
oxidase’ activity cannot be ruled out completely, our demonstra-
tion that GliT exhibits gliotoxin reductase activity (Figure 5)
suggests that direct gliotoxin reduction is a pre-requisite for
secretion from A. fumigatus via a GliT-mediated pathway or as a
component of the auto-protective mechanism deployed against
exogenous gliotoxin secreted by adjacent fungi in the environment
(Figure 7). This hypothesis is firmly supported by the absence of
gliotoxin secretion in A. fumigatus DgliT
26933. Given the potential of
reduced gliotoxin to thiolate cellular proteins, we speculate that
reduced gliotoxin may be sequestered into intracellular vesicles
where it is converted to the oxidized form, by an unidentified
activity, prior to release from the cell by an exocytotic mechanism
complementary to GliA-mediated efflux (Figure 7). It remains
possible that GliT-mediated gliotoxin oxidase activity may be
associated with disulfide bridge closure during gliotoxin biosyn-
thesis when intracellular levels of gliotoxin can be regulated more
precisely by the organism. Thus, GliT could be necessary to
maintain a balance between reduced and oxidised gliotoxin in A.
Figure 7. A proposed model for GliT functionality in A. fumigatus based on experimental observations. Exogenous gliotoxin enters A.
fumigatus (1) and is converted to the reduced form intracellularly by GliT (gliotoxin reductase activity (2)). GliT may also be necessary to oxidize reduced
gliotoxin during biosynthesis in A. fumigatus. Given the toxicity of the intracellular form of reduced gliotoxin, we predict that it may be imported into
intracellular vesicles, possibly with concomitant oxidation for storage (3). GliA function to facilitate gliotoxin efflux (4) is extrapolated from the
observation in L. maculans that this protein confers resistance to exogenous gliotoxin [13]. In the absence of GliT, gliotoxin may be alternately reduced
by intracellular GSH (5) leading toa depletionin GSHandcell death/growtharrestandalso modificationof other cellularproteins leading to inactivation
or activity modification (6). In this model, absence of GliT would lead to the build up of gliotoxin within the cell and also the inability to reduce
exogenously added gliotoxin. Reduced gliotoxin may not enter but converts to the oxidized form in a time-dependent manner (7, 7A).
doi:10.1371/journal.ppat.1000952.g007
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corresponding to a monothiol form of gliotoxin, in culture
supernatants from A. fumigatus DgliT is interesting, and we
hypothesize that this metabolite may represent a breakdown
product of gliotoxin. Future work will involve purification and
complete characterization of this molecule. The observation that
GliT-specific IgG was present in human sera was unexpected and
implies that GliT is either present in inhaled conidia or is
expressed during abortive conidial germination in immunocom-
petent individuals. However, our observation suggests that the
option of using normal human sera as a source of immunoaffinity
antibodies, following Ig isolation and purification using a
recombinant antigen (e.g., GliT), represents a novel approach
for readily obtaining monospecific antisera against antigenic A.
fumigatus proteins.
The animal model system deployed herein appears to distinguish
between virulence diminution associated with lack of gliotoxin
production, since inoculation with A. fumigatus DgliZ resulted in
reduced Gallerial mortality than exposure to wild-type A. fumigatus.
This result extends previous observations with respect to the potential
avirulence of A. fumigatus DgliZ [14]. However, the relatively
equivalent virulence observed for A. fumigatus wild-type and DgliT,
whereby the latter doesnot produce gliotoxin issomewhat at variance
with the A. fumigatus DgliZ findings. We suggest that alterations in the
levels of additional metabolites in A. fumigatus DgliZ,a sn o t e di n[ 1 4 ] ,
or a possible cytotoxic role in G. mellonella for the putative monothiol
form of gliotoxin secreted by A. fumigatus DgliT may account for this
dichotomy. Our demonstration that gliT is expressed independently
of other cluster components implies that previous virulence model
experimentation, involving gliP-a n dgliZ –deficient mutants [9–12],
may require interpretation in light of the possibility of independently
regulated gliT expression, or GliT functionality. Indeed, if it is ever
demonstrated that gliT expression occurs in the absence of gli cluster
expression/gliotoxin biosynthesis (as has been demonstrated herein
for A. fumigatus DgliZ), or is regulated by factors other than exposure to
exogenous gliotoxin, then consideration may need to be given to this
phenomenon in future studies. This consideration is based on the fact
that independent regulation of gliT may have enabled acquisition of
functionality beyond a role in gliotoxin biosynthesis or auto-
protection.
Genetic modification of filamentous fungi for the improved
production of food additives, industrial enzymes or pharmaceu-
ticals is an ongoing requirement of the biotechnological industry
[26,27]. Antibiotic-producing fungi are continually subjected to
strain improvement, with a concomitant requirement for new
selection markers, to increase product yield and decrease the level
of unwanted side-products [28]. Our observation that gliT
complementation in A. fumigatus can be selected for in the presence
of gliotoxin, without the use of conventional selection markers, and
that transformation of A. nidulans and S. cerevisiae with gliT confers
enhanced resistance to gliotoxin offers the possibility of using the
gliT/gliotoxin combination to select for fungal transformation.
Moreover, acquired gliotoxin resistance in A. nidulans and S.
cerevisiae resulting from gliT presence, underpins the important role
played by this gene in mediating resistance to exogenous gliotoxin.
Gliotoxin isolated from cultures of a marine fungus from the genus
Pseudallescheria has been shown to possess both anti-bacterial and
free-radical scavenging capability whereby an MIC50 of 1 mg/ml
was observed against methicillin-resistant Staphylococcus aureus [29].
Gliotoxin may also provide a competitive advantage for A.
fumigatus when grown in the presence of other fungi [30]. In this
regard, gliotoxin production has been detected when A. fumigatus
was co-cultured, at both 30 and 37uC, with a range of other
Aspergillus spp., leading the authors to speculate that co-expression
of resistance genes may allow toxin producers to resist the effects of
their own biological arsenal in competitive co-culture situations
[30]. The parallel between this supposition, and our observation of
GliT-mediated resistance to exogenous gliotoxin, is vivid.
The vast majority of literature surrounding the role of gliotoxin
in A. fumigatus focuses on its function as a cytotoxic molecule which
has deleterious effects on cells within infected individuals and
exhibits anti-microbial activity [5,6,9–12,29,30]. However, based
on our observations and significant other literature [16,18,31], a
credible alternative hypothesis is that gliotoxin may actually be
part of the intracellular antioxidant defense system within A.
fumigatus, and is a molecule, analogous to thioredoxin or 2-cys
peroxiredoxin, which may undergo rapid changes in redox status
to buffer against specific exogenous or endogenous oxidants. In
other words, the cytotoxic effects of gliotoxin in infected host cells
may actually be an indirect consequence of its role within A.
fumigatus. This alternative hypothesis is not without support. Firstly,
Watanabe et al. [31] have shown that the cytotoxicity of A. fumigatus
culture filtrates was significantly attenuated, or absent, when
cultures were grown under reduced aerobic or anaerobic
conditions. Interestingly, gliotoxin production was detectable by
GC-MS analysis from aerobic but not in reduced aerobic culture
supernatants. Although Watanabe et al. concluded that their results
indicated that gliotoxin production is increased to facilitate fungal
pathogenicity (mimicking the aerobic lung environment), an
alternative conclusion, which is in accordance with our thinking,
is that gliotoxin production is actually elevated to cope with
increased oxygen levels and that secretion of gliotoxin forms part
of the gliotoxin homeostasis control mechanism within A. fumigatus
to prevent the side-effect of intracellular oxidative stress. As noted
earlier, in animal cells it has been shown that gliotoxin may
substitute for 2-cys peroxiredoxin activity in HeLa cells by
accepting electrons from NADPH via the thioredoxin reductase–
thioredoxin redox system to reduce H2O2 to H2O. In this way,
nanomolar levels of gliotoxin may actually protect against
intracellular oxidative stress [18]. Additionally, as demonstrated
by Srinivasan et al. [16], oxidized gliotoxin facilitates selective
protein inactivation in the presence of molecular oxygen which,
we hypothesise, could prevent global intracellular damage due to
resultant reactive oxygen species. Moreover, a protective role for
gliotoxin against environmental stress in A. fumigatus has been
considered [2,13]. Our observations and consequent hypothesis
now provide a vehicle to explore this proposal.
Insummary,wehavedemonstratedthatGliT playsa majorauto-
protective role against gliotoxin toxicity in A. fumigatus which points
to alternative gliotoxin functionality in A. fumigatus. From a
utilitarian viewpoint, gliT/gliotoxin sensitivity represents a potential
new selection marker strategy for fungal transformation. The trans-
fungal implications of our observations remain to be explored.
Materials and Methods
Ethics statement
This study was conducted according to the principles expressed
in the Declaration of Helsinki. Ethical permission was obtained
from The Ethics Committee of NUI Maynooth for the use of
human serum specimens. Anonymous serum specimens were
obtained with the signed agreement of the Irish Blood Transfusion
Service.
Strains, growth conditions, and general DNA
manipulation
In general, A. fumigatus strains (Table 1) were grown at 37uCi n
Aspergillus minimal media (AMM). AMM contained 1% (w/v)
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source, and trace elements according to Pontecorvo et al. [32].
Liquid cultures were performed with 200 ml AMM in 500 ml
Erlenmeyer flasks inoculated with 10
8 conidia. For growth assays,
10
4 conidia of the respective strains were point inoculated on
AMM plates, containing the relevant supplements and incubated
for 48 h at 37uC.
TOPO TA cloning system (Invitrogen) and TOP10 E. coli cells
(F-mcrA D(mrr-hsdRMS-mcrBC) w80lacZDM15 DlacX74 recA1
araD139 galU galK D (ara-leu)7697 rpsL (Str
R) endA1 nupG) were
used for general plasmid DNA propagation and A. fumigatus
genomic DNA was purified using a ZR Fungal/Bacterial DNA Kit
(Zymoresearch).
Generation of A. fumigatus mutant strains
For generating DgliT mutant strains, the bipartite marker
technique was used [20]. Briefly, A. fumigatus strains ATCC46645
and ATCC26933 were co-transformed with two DNA constructs,
each containing an incomplete fragment of a pyrithiamine
resistance gene (ptrA) [21] fused to 1.2 kb, and 1.3 kb of gliT
flanking sequences, respectively. These marker fragments shared a
557 bp overlap within the ptrA cassette, which served as a potential
recombination site during transformation. During transformation,
homologous integration of each fragment into the genome flanking
gliT allows recombination of the ptrA fragments and generation of
the intact resistance gene at the site of recombination. Two rounds
of PCR generated each fragment. First, each flanking region was
amplified from ATCC46645 genomic DNA using primer ogliT1
and ogliT4 for flanking region A (1.3 kb), and ogliT-2 and ogliT-3
for flanking region B (1.2 kb). Subsequent to gel-purification, the
fragments were digested with SpeI and HindIII, respectively. The
ptrA selection marker was released from plasmid pSK275 (a kind gift
from Sven Krappmann, Goettingen, Germany) by digestion with
SpeI and HindIII, and ligated with the two flanking regions A and B
described above. For generation of DgliT, two overlapping
fragments were amplified from the ligation products using primers
ogliT-5 and optrA-2 for fragment C (2.6 kb) and primers ogliT-6
and optrA-1 for fragment D (2.2 kb). Subsequently ATCC46645
and ATCC26933 were transformed simultaneously with the
overlapping fragments C and D. In the generated mutant allele of
DgliT-ptrA the deleted region comprises amino acids 1–325 of gliT.
For reconstitution of the DgliT strain with a functional gliT copy,
a 3.2 kb PCR fragment, amplified using primers ogliT-5 and
ogliT-6, was subcloned into pCR2.1-TOPO (Invitrogen). The
resulting 7.1 kb pgliT was linearised with AatII and used to
transform A. fumigatus DgliT protoplasts. Taking advantage of the
decreased resistance of the DgliT mutant to exogenous added
gliotoxin DgliT protoplasts were transformed with pgliT and
screened for wild-type resistance to gliotoxin for genetic comple-
mentation. Positive deletion- and reconstituted- strains were
screened by Southern analysis (Figure S1) and DIG-hybridisation
probes were generated using primers ogliT-5 and ogliT-4.
To obtain knock-out constructs for the deletion of gliH a5 9
flanking region with oligos ogliH1 and ogliH4 was amplified. For
the 39 flanking region a PCR with oligos ogliH2 and ogliH3 was
performed. Amplicons were digested with SpeI and HindIII,
respectively. Resulting fragments were ligated to a ptrA cassette,
released from pSK275 via SpeI and HindIII digest. Final PCRs
were obtained using oligos ogliH5/optrA2 and ogliH6/optrA1
and used for transformation.
To complement DgliH and DgliT
26933 with a functional copy of
gliH, oligos ogliT7 and M13 were used to amplify a PCR-fragment
using pgliT as template. This fragment digested with EcoRI and
SacII was cloned into pBS-KS (Stratagene), resulting in pgliH.
Together with pAN7-1 [33], pgliH was used to complement A.
fumigatus DgliH and DgliT
26933.
GliT was C-terminally fused in frame to gfp (green fluorescent
protein) to determine its subcellular localisation. To this end, a
fragment containing gliT was amplified using oligos ogliT-5-SphI
and ogliT-16. The resulting 2.2 kb fragment was sub-cloned into
pCR2.1-TOPO (Invitrogen) and sequenced. Via SphI digest a
fragment containing the gliT promoter region and the coding
sequence was released and cloned into the corresponding SphI site
of pgfp, resulting in pgliTgfp. To obtain pgfp, a gfp containing
fragment was released from pUCG-H [34] via SmaI and SacI and
subcloned into the corresponding EcoRV and SacI sites of
pGEM5zf+ (Promega). The plasmid pgliTgfp was used to
transform DgliT protoplasts via co-transformation using a
phleomycin resistance gene. Phleomycin resistant transformants
carrying an in-frame gliT-gfp fusion were used to localize GliT
using fluorescence microscopy. Positive, GliT-GFP harbouring
strains were screened by Southern analysis and hybridization
probes were generated using oligos ogliT-7 and ogliT-8. A.
fumigatus transformation was carried out according to Tilburn et al.
[35]. In order to obtain homokaryotic transformants, colonies
from single homokaryotic spores were picked and single genomic
integration was confirmed by PCR (data not shown) and Southern
blot analysis.
Northern analysis
RNA was isolated using TRI-Reagent (Sigma-Aldrich). Equal
concentrations of total RNA (10 mg) were size-separated on 1.2%
agarose-2.2 M formaldehyde gels and blotted onto Hybond N+
membranes (Amersham Biosciences). The hybridisation probes
used in this study were generated by PCR using primers ogliA1
and ogliA2 for AFUA_6G09710, ogliG7 and ogliG8 for
AFUA_6G09690, ogliT7 and ogliT8 for AFUA_6G09740, and
ogliZ1 and ogliZ2 for AFUA_6G09630. All primers used in this
study are listed in Table 2.
Proteomic analysis of GliT expression
A. fumigatus ATCC26933 was cultured (n=3) for 21 h in
Sabouraud media followed by gliotoxin addition for 3 h (final
Table 1. A. fumigatus and A. nidulans strains used in this
study.
Strain Genotype Reference
ATCC46645 Wild-type Hearn et al. [43]
ATCC26933 Wild-type Taylor et al. [44]
DgliZ DgliZ::pyrG Bok et al. [14]
gliZ
c DgliZ::gliZ::hygB Bok et al. [14]
DgliT
46645 ATCC46645; gliT::ptrA This study
DgliT
26933 ATCC26933; gliT::ptrA This study
gliT
C DgliT; DgliT::gliT This study
gliT
gfp DgliT
46645;( p ) gliTgfp This study
A. nidulans WGTRAN Wild-type Oberegger et al. [45]
An
gliT TRAN; (p)gliT This study
DgliH ATCC26933; gliH::ptrA This study
DgliT
26933gliH ATCC26933; gliT::ptrA; This study
(p)gliH; (p)AN7-1
gliH
C DgliH;( p ) gliH; (p)AN7-1 This study
doi:10.1371/journal.ppat.1000952.t001
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was not added, were also performed. Mycelia were harvested,
lysed and subject to MALDI-ToF mass spectrometric analysis as
previously described [36] and Imagemaster analysis (GE
Healthcare).
Analysis of gliotoxin production
To analyze gliotoxin, or related metabolite production, A.
fumigatus wild-type and mutant strains were grown up at 37uC for
72 h in Czapeks-Dox. Supernatants were chloroform extracted
overnight and fractions were lyophilized to complete dryness.
Samples were resolubilised in MeOH and analysed using a
reversed phase HPLC as described in [37] and LC-MS (Agilent
6340 ETD LC-MS system). Samples (1 ml) were loaded onto a
Zorbax 300SB C-18 Nano-HPLC Chip (150 mm675 mm,
Agilent) with 0.1%(v/v) formic acid (0.6 ml/min), and compounds
eluted by an increasing 0.1%(v/v) formic acid, acetonitrile
gradient (90%(v/v) final). Eluted compounds were directly ionised
and analysed by ion trap mass spectrometer (Agilent). For each
round of MS the two most abundant compounds were
automatically selected for MS
n analysis. Gliotoxin was identified
by its whole mass of 326.4 m/z and its characteristic MS
n
fragmentation pattern (263, 245 and 227 m/z). LC-ToF analysis
was performed using an Agilent HPLC 1200 series using
electrospray ionisation inputted into a ToF (Agilent). LC
separation was via an XDB C18 column (4.66150 mm) using a
water/acetonitrile (both containing 0.1% (v/v) formic acid)
gradient at a flow rate of 0.5 ml/min. The gradient was started
at 50% (v/v) acetonitrile, which was increased to 100%
acetonitrile in 10 min; 100% acetonitrile was maintained for
5 min before the gradient was returned to starting conditions.
Spectra were collected at 0.99 spectra per second.
Cloning and expression of gliT
The gliT sequence was amplified from cDNA using primers
incorporating terminal XhoI and HindIII sites to facilitate downstream
cloning. PCR products were cloned into the pCR2.1 cloning vector
(Invitrogen, Carlsbad, CA, USA) according to the manufacturer’s
instructions. gliT was subsequently cloned into the pProEX-Htb
expression vector (Invitrogen). Ligations were performed using
Quickstick ligase (Bioline, London, UK) according to the manufac-
turer’s instructions. pPXAgliT, the resultant expression vector was
transformedintoE. coli strainBL21bystandardprotocols.Expression
of GliT was induced by the addition of isopropyl b-D-thiogalactoside
(IPTG; to 0.6 mM) and monitored by SDS-PAGE and Western blot
analysis. Recombinant GliT purification was undertaken by
differential extraction. Protein concentrations were determined using
t h eB r a d f o r dm e t h o d[ 3 8 ]w i t hb o v i n es e r u ma l b u m i na sas t a n d a r d .
Purification of native GliT from A. fumigatus by ion-
exchange chromatography
A. fumigatus ATCC46645 mycelia were ground in liquid nitrogen
and lysed in ice-cold lysis buffer as described [36] following
incubation with gliotoxin (10 mg/ml) for 3 h). Following centrifu-
gation (12,000 g; 30 min), the lysate supernatant (176 ml) was
ammonium sulphate precipitated (10, 20, 50 and 70% ammonium
sulphate). The 50% pellet was resuspended in 20 mM Bis-Tris
propane pH 7.6 and dialysed three times against 50 volumes of the
same buffer at 4uC. The dialysate was centrifuged (12,000 g;
20 min) and filtered (0.45 mm) to remove particulates. The dialysate
was loaded onto an equilibrated Q-Sepharose ion-exchange (IEX)
column (4 ml) at a flow rate of 1 ml/min. The column was washed
with 20 mM Bis-Tris propane pH 7.6 before bound protein was
eluted using an NaCl gradient (0.5 M final). Absorbance detection
was at 280 nm and 454 nm. Collected fractions were subjected to
SDS-PAGE, Western blot and activity analysis for GliT.
Immunoaffinity purification of human IgG [anti-GliT]
Serum specimens (provided by the Irish Blood Transfusion
Service, Dublin, Ireland according to institutional guidelines)
containing high titer IgG [anti-GliT] were pooled, diluted 1 in 4 in
PBS, and applied to a GliT-Sepharose affinity column (0.5 ml),
prepared as per manufacturer’s instructions. After removal of
unbound proteins by PBS washing, immobilised IgG [anti-GliT]
was eluted using 100 mM glycine pH 2.8, followed by immediate
neutralization using 100 mM Trizma base pH 8.3. Resultant
immunoaffinity purified (IAP) IgG [anti-GliT] was used to detect
native GliT by Western analysis.
GliT activity assay and removal of native GliT from A.
fumigatus by IAP pulldown
A. fumigatus ATCC46645 mycelia were ground in liquid nitrogen
and lysed in ice-cold lysis buffer and bead-beating as described
Table 2. Primers used in this study.
Primer Sequence (59–39)
ogliA-1 TGG ATC GTT GAT CTG CGC
ogliA-2 ATG GCC TGG TAT CCG ATC
ogliG-7 GAC CCT CCG ATC TTG TAG
ogliG-8 TTC TCG CCA TGG CCA AAC
ogliT-1 AGC GCA TTG GAC AGG TTG TAG
ogliT-2 GGA CAC GTC TAG CAT GGA CTG G
ogliT-3 GCT AAG CTT TTG CCG GAG TTT CGT CTC
ogliT-4 GGA CTA GTT ATG CGC GAG AGT AGT GG
ogliT-5 TCT GCG CTT CTT GAT CGG
ogliT-6 ACG GTG CTG GGA ATG ATC
ogliT-7 GTC GAC GTG CTC ATC ATC
ogliT-8 GCC AAA GAT CCC ATC GAC
ogliT-5-SphIC G G CAT GCT CTG CGC TTC TTG ATC GG
ogliT-16 AAA GCA TGC TAG CTCCTG ATC GAG ACG
ogliZ-1 GCT ATG CAG GAT GTG TCG
ogliZ-2 CGG CCA TGC TAA TAC TGC
optrA1 GAG GAC CTG GAC AAG TAC
optrA2 CAT CGT GAC CAG TGG TAC
ogliT-BglII CCA GAT CTA TGT CGA TCG GCA AAC TAC
ogliT-NotI ATA GCG GCC GCC TAT AGC TCC TGA TCG AGA
ogliH1 CAT GCA CAA CGT CCT CGG ATG
ogliH2 GCT CCT GGG GAT TCT GAG CGC
ogliH3 AAC AAG CTT AGA ATG GGC AGT TGG ACG
ogliH4 GCT ACT AGT GAA GAT CTG TCT GCC GTC
ogliH5 TCC ACC ATC CAG TTC CAG
ogliH6 GCG GTG CAG TGA ACT AAC
M13 GTAAAACGACGGCCAGT
M13rev AACAGCTATGACCATG
Sc-gliT-F CCCGGGCATATGTCGATCGGCAAACTACTCTCAAC
Sc-gliT-R CCCGGGGCATGCCTATAGCTCCTGATCGAGACGAAAC
Added restriction enzyme sites are underlined.
doi:10.1371/journal.ppat.1000952.t002
GliT Function in A. fumigatus
PLoS Pathogens | www.plospathogens.org 12 June 2010 | Volume 6 | Issue 6 | e1000952elsewhere [36]. Following centrifugation (12,000 g; 30 min), the
lysate supernatants were used to determine gliotoxin reductase
activity (DA340 nm) in the presence of gliotoxin (9 mM) and
NADPH (200 mM) at pH 7.2 (a modified version of Hill et al.
[39]). A. fumigatus cell lysates were also subjected to ion-exchange
chromatography and a pooled IEX fractions (250 ml) incubated
with IAP human IgG [anti-GliT] (100 ml) followed by Protein A-
Sepharose addition and centrifugation (10,000 g; 10 min). Super-
natant activity analysis as described above.
GliT-GFP confocal microscopy
A. fumigatus gliT
gfp and ATCC46645 mycelia were grown in cell
culture six well plates (Corning Inc.) for 21 h before induction with
(or without) gliotoxin (5 mg/ml). Mycelia were removed from the
wells and centrifuged (12,000 g; 5 min). Supernatants were stored
while pellets were resuspended in DAPI staining solution and
incubated (5 min) at room temperature. The stained mycelia were
centrifuged and washed with deionised H2O before resuspension
in the original supernatant. Aliquots of these preparations were
analysed for GliT-GFP presence and DAPI fluorescence on an
Olympus Fluoview 1000 confocal microscope.
Virulence model
G. mellonella larvae (n=10) were inoculated into the hind pro-leg
with 10
6 A. fumigatus conidia in 20 ml (per larva) [37]. In addition,
one cohort of larvae was pre-treated with gliotoxin (0.5 mg/larva
in 20 ml). Control treatments were included to ensure that neither
the injection procedure, or the incubation period, were responsible
for any mortality observed. These controls involved G. mellonella
larvae injected with 20 ml of sterile PBS or gliotoxin alone. G.
mellonella larvae were placed in Petri-dishes and incubated in the
dark at 30uC. Mortality rates were recorded for 72 h post-
injection. Mortality was assessed based on lack of movement in
response to stimulation and discolouration (melanisation) of the
cuticle.
Generation of gliT-encoding Aspergillus nidulans and
Saccharomyces cerevisiae
To introduce gliT in A. nidulans TRAN, a plasmid containing
gliT coding sequence under the control of a constitutive otef [40]
promoter was used. Therefore, a 1.1 kb fragment containing gliT
was amplified using ogliT-BglII and ogliT-NotI and subcloned into
pCR2.1-TOPO (Invitrogen). A 0.9 kb fragment containing an otef
promoter was released via BamHI/KpnI digest from plasmid
pUCG-H [34] and cloned into the respective sites into pGliT-
BglII-NotI. Transformation was performed as described for A.
fumigatus.
The S. cerevisiae strain used in this study was BY4741 (MATa
his3D1 leu2D0 met15D0 ura3D0) and was purchased from Euroscarf.
Rich and minimal yeast medium was as described in [41], and
gliotoxin was added to the desired concentration to cooled molten
agar. To monitor the effects of GliT expression in S. cerevisiae gliT
was amplified from A. fumigatus (ATCC46645) using PCR with
primers Sc-gliT-F and Sc-gliT-R (Table 2), and cloned into the
yeast shuttle vector pC210 [42]. Plasmids pC210 harbors the SSA1
coding sequence under control of the constitutive SSA2 promoter.
Following digestion of pC210 with NdeI and SphI to remove the
SSA1 coding sequence, similarly digested gliT PCR product was
ligated into pC210 to create pC-GliT. Thus, pC-GliT harbors A.
fumigatusgliT undercontrolofthestrong constitutive S.cerevisiaeSSA2
promoter. The integrity of pC-GliT was confirmed by sequencing.
To test the sensitivity of yeast to gliotoxin, BY4741 harboring
either vector alone (pRS315) or pC-GliT was grown to mid-
exponential phase (3610
6 cells/ml). Cells were harvested and
resuspended in rich medium to a concentration of 5610
6 cells/ml.
Cells were serially diluted and were plated onto rich or minimal
medium containing the desired concentration of gliotoxin, using a
multi-pronged replicator. Plates were incubated at 30uC for 48 h
with further monitoring of plates at room temperature for 72 h.
Accession numbers
The proteins named herein are available at Genbank under the
following Accession numbers: GliA (AAW03302); GliF
(AAW03300); GliG (AAW03304); GliH/AFUA_6G09745
(EAL88826); GliT (AAW03299) and GliZ (AAW03310).
Supporting Information
Protocol S1 Supplementary data.
Found at: doi:10.1371/journal.ppat.1000952.s001 (0.03 MB
DOC)
Figure S1 (A) Deletion of gliT and gliH in A. fumigatus
ATCC46645 and 26933, respectively. Southern analysis of DgliT
mutant versus wild-type DNA for A. fumigatus ATCC46645 and
ATCC26933, respectively. Here, a DIG-labelled probe was used
to detect the predicted presence of 3.3 and 6.4 kb fragments in
XbaI restricted DgliT and wild-type DNA, respectively. (B)
Southern Blot analysis of DgliT complemented strains (gliT
C).
Genomic DNA of wild-type and complemented strains was
digested with NarI (ATCC46645) and ApaI (ATCC26933),
respectively and probed using a DIG-labelled probe amplified
using oligos ogliT-4 and ogliT-5. (C) Southern Blot analysis of
DgliH, DgliH-complemented strains (gliH
C) and DgliT-complement-
ed with gliH (DgliT
26933gliH). Genomic DNA of wild-type and
respective mutant strains was digested with NdeI (ATCC26933)
and probed using a DIG-labelled probe amplified using oligos
ogliH-4 and ogliH-5. (1) A. fumigatus ATCC26993, (2) DgliH, (3)
gliH
C, (4) DgliT, (5) DgliT
26933gliH.
Found at: doi:10.1371/journal.ppat.1000952.s002 (1.30 MB
DOC)
Figure S2 Phenotypic analysis of A. fumigatus ATCC46645 (wild-
type) and DgliT strains in the presence of gliotoxin (GT).
Compared to wild-type, gliotoxin (5 mg/ml) significantly inhibits
DgliT growth in minimal medium (MM) and completely inhibits
DgliT growth in both MM and Sabouraud medium (10 mg/ml).
Found at: doi:10.1371/journal.ppat.1000952.s003 (0.04 MB
DOC)
Figure S3 Peptide mass spectrum of GliT from A. fumigatus
ATCC26933, a component of the gliotoxin biosynthetic cluster
(33% sequence coverage). This MALDI-ToF identification
represents the first proteomic confirmation of the expression of a
component of the gliotoxin biosynthetic cluster.
Found at: doi:10.1371/journal.ppat.1000952.s004 (0.11 MB
DOC)
Figure S4 Analysis of gliotoxin, and related metabolite,
production in A. fumigatus mutant strains. (A) Gliotoxin was
detectable by RP-HPLC (data not shown) and LC-MS in A.
fumigatus ATCC26933 gliT
c with identical molecular mass and
fragmentation pattern to commercially available gliotoxin and as
reported in [10]. (B) LC-ToF analysis of RP-HPLC purified
gliotoxin-related metabolite (Figure 3B) from Aspergillus fumigatus
DgliT
26933. MS spectrum shows the presence of a high abundance
molecular ion (Retention time =9.153 min) with m/z 279.0796
(M+H)
+ (557.1497 (2M+H)
+) which corresponds precisely to a
predicted molecular formula of C13 H14 N2 O3 S - a putative
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HPLC purified gliotoxin-related metabolite (Figure 3B) from
Aspergillus fumigatus DgliT
26933. Using a manual approach, LC-MS
software identified five molecular species with m/z 279.0. The
most intense peaks (1 and 5) were subjected to MS2 analysis and
both yielded identical fragments ions of m/z 261.1, 231.0 and
203.1. Notably, peak 1 eluted from LC-MS and LC-ToF with an
identical retention time (9.1 min) (D) Gliotoxin production was
undetectable in A. fumigatus DgliH
26933, by RP-HPLC and LC-MS
(data not shown), thereby indicating a role for this gene in either
gliotoxin biosynthesis or secretion.
Found at: doi:10.1371/journal.ppat.1000952.s005 (0.43 MB
DOC)
Figure S5 Recombinant GliT expression. (A) SDS-PAGE and
(B) Western blot analysis of recombinant GliT expression and
solubility. Lane 1 contains non-transformed BL21 (DE3) cells.
Lane 2 contains non-induced cell extract and lanes 3–5 contain
induced cell extracts taken 1–3 h post-induction with 0.6 mM
IPTG. Lane 6 and 7 contain soluble and insoluble cell extracts
respectively. Lane 8 contains His-tag positive control and lane 9
contains non-reducing cell extract- monomeric (m) and dimeric (d)
forms of GliT are evident. Lane M contains molecular mass
marker.
Found at: doi:10.1371/journal.ppat.1000952.s006 (2.29 MB
DOC)
Figure S6 Confirmation of recombinant GliT identity by
MALDI-ToF mass spectrometry (21% sequence coverage).
Found at: doi:10.1371/journal.ppat.1000952.s007 (0.03 MB
DOC)
Figure S7 (A) Partial purification and immunological identifica-
tion of GliT. Absorbance (A280 nm and A454 nm) versus elution
volume (ml) for a Q-Sepharose ion-exchange fractionation of GliT
dialysate (post-ammonium sulphate precipitation). (B) SDS-PAGE
analysis of Q-Sepharose ion-exchange chromatography (IEX)
fractions. (C) Western blot analysis of Q-Sepharose IEX fractions
using human IgG[anti-GliT] and anti-human IgG-HRP conjugate
with ECL detection. These fractions were pooled and used for
activity and immunological analysis as shown in Figures 4 and 5.
Found at: doi:10.1371/journal.ppat.1000952.s008 (0.29 MB
DOC)
Figure S8 Gliotoxin induces expression of GliT-GFP expression
in A. fumigatus. (A) Basal expression of GliT-GFP expression,
determined by confocal fluorescence microscopy in A. fumigatus in
the absence of added gliotoxin. Panel I: GliT-GFP fluorescence,
panel II: DAPI nuclear staining and panel III: Image merge. (B)
Enhanced expression of GliT-GFP throughout mycelia following
exposure to gliotoxin (5 mg/ml). Panel I: GliT-GFP fluorescence,
panel II: DAPI nuclear staining and panel III: image merge. (C)
Fluorescence intensity for DAPI (blue) and GFP (green) are shown.
Yellow line corresponds to the fluorescence intensities depicted
with a red arrow. Intensities demonstrate localisation of GliT-GFP
in cytoplasm and nuclei.
Found at: doi:10.1371/journal.ppat.1000952.s009 (1.42 MB
DOC)
Figure S9 Expression of GliT-GFP restores resistance to
exogenous gliotoxin. Phenotypes of A. fumigatus ATCC46645
(WT), DgliT
46645, gliT
C and gliT
gfp. Conidia of the respective strain
were point inoculated on AMM plates in the absence and presence
of gliotoxin (5 and 10 mg/ml. respectively) and incubated for 40 h
at 37uC.
Found at: doi:10.1371/journal.ppat.1000952.s010 (0.62 MB
DOC)
Figure S10 Virulence assay of A. fumigatus wild-type, DgliZ, DgliT
and gliT
c. (A and B) G. mellonella challenged with A. fumigatus DgliZ
[14], corresponding wild-type, DgliT
26933 and gliT
c in the presence
(A) (6 ng, pre-incubation 2 hr prior to conidial challenge) and
absence (B) of gliotoxin.
Found at: doi:10.1371/journal.ppat.1000952.s011 (0.24 MB
DOC)
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